Related Experiment Video
Updated: Dec 18, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
7.2K
Predicting Responses to Bariatric and Metabolic Surgery
Anna Belligoli1, Silvia Bettini1, Gianni Segato2
1Center for the Study and the Integrated Treatment of Obesity, Padova University Hospital, Padova, Italy.
Current Obesity Reports
|June 17, 2020
Summary
Predicting bariatric surgery outcomes remains challenging, as pre-operative factors show limited predictive power for weight loss and diabetes remission. Post-operative behaviors are more influential for long-term success.
Area of Science:
- Bariatric Surgery
- Obesity Medicine
- Metabolic Surgery
Background:
- Bariatric surgery is a leading treatment for severe obesity and associated comorbidities.
- Significant variability exists in patient outcomes following bariatric procedures.
- Predictive factors could optimize patient selection and post-operative management.
Purpose of the Study:
- To review predictive factors for weight loss, weight regain, and diabetes remission/recurrence after bariatric surgery.
- To assess the clinical utility of pre-operative predictors versus post-operative factors.
Main Methods:
- Literature review of studies on pre-operative and post-operative predictors of bariatric surgery outcomes.
- Analysis of factors influencing weight loss, weight regain, and diabetes remission.
Main Results:
- No single pre-operative factor consistently predicts weight loss with sufficient accuracy.
- Post-operative behavioral factors, including lifestyle modifications, are more critical for weight regain and long-term diabetes remission.
- While scores exist for predicting initial diabetes remission, maintenance and recurrence depend heavily on post-operative adherence.
Conclusions:
- Current pre-operative predictors have limited value for patient selection in bariatric surgery.
- Focusing on pre-operative and post-operative eating behaviors and lifestyle interventions is crucial for improving long-term outcomes.
- Clinical practice should prioritize behavioral support over solely relying on pre-operative predictive markers.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
158
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
158
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
115
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
115

